Mechanism-based inhibitors: Development of a high throughput coupled enzyme assay to screen for novel antimalarials

被引:10
|
作者
Hariharan, J
Rane, R
Ayyanathan, K
Philomena
Kumar, VP
Prahlad, D
Datta, S
机构
[1] Astra Biochem India, Bangalore 560080, Karnataka, India
[2] Wistar Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.1177/108705719900400406
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Identifying potent enzyme inhibitors through a robust HTS assay is currently thought to be the most efficient way of searching for lead molecules. We have developed a HTS assay that mimics a crucial step in an essential metabolic pathway, the purine salvage pathway of the malarial parasite Plasmodium falciparum. In this assay we have used purified recombinant enzymes: hypoxanthine guanine phosphoribosyl transferase (HGPRT) and inosine monophosphate dehydrogenase (IMPDH) from the malarial parasite and the human host, respectively. These two enzymes, which work in tandem, are used to set up a coupled assay that is robust enough to meet the stringent criteria of an HTS assay. In the first phase of our screen we seem to have identified novel inhibitors that kill the parasite by inhibiting the salvage pathway of the parasite.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 50 条
  • [41] Thales Technologies AG - Mechanism-based high-throughput screening of catalysts
    Hinderling, C
    Adlhart, C
    Chen, P
    CHIMIA, 2000, 54 (04) : 232 - 235
  • [42] Establishment of a mechanism-based in vitro coculture assay for evaluating the efficacy of immune checkpoint inhibitors
    Myeong Joon Kim
    Kyeong Hee Hong
    Bo Ryeong Lee
    Sang-Jun Ha
    Cancer Immunology, Immunotherapy, 2022, 71 : 2777 - 2789
  • [43] Establishment of a mechanism-based in vitro coculture assay for evaluating the efficacy of immune checkpoint inhibitors
    Kim, Myeong Joon
    Hong, Kyeong Hee
    Lee, Bo Ryeong
    Ha, Sang-Jun
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (11) : 2777 - 2789
  • [44] Assay for ubiquitin ligase activity: High-throughput screen for inhibitors of HDM2
    Davydov, IV
    Woods, D
    Safiran, YJ
    Oberoi, P
    Fearnhead, HO
    Fang, S
    Jensen, JP
    Weissman, AM
    Kenten, JH
    Vousden, KH
    JOURNAL OF BIOMOLECULAR SCREENING, 2004, 9 (08) : 695 - 703
  • [45] A High-Throughput Enzyme-Coupled Assay for SAMHD1 dNTPase
    Seamon, Kyle J.
    Stivers, James T.
    JOURNAL OF BIOMOLECULAR SCREENING, 2015, 20 (06) : 801 - 809
  • [46] A high throughput colorimetric assay for angiotensin I-converting enzyme and its inhibitors
    Karakkat, Jimsheena V.
    Gowda, Lalitha R.
    FASEB JOURNAL, 2009, 23
  • [47] Development of a high-throughput method to screen novel antiviral materials
    Nakakido, Makoto
    Tanaka, Naoki
    Shimojo, Ayako
    Miyamae, Nobuhiro
    Tsumoto, Kouhei
    PLOS ONE, 2022, 17 (04):
  • [48] Development of human lactate dehydrogenase a inhibitors: high-throughput screening, molecular dynamics simulation and enzyme activity assay
    Shu, Yuanyuan
    Yue, Jianda
    Li, Yaqi
    Yin, Yekui
    Wang, Jiaxu
    Li, Tingting
    He, Xiao
    Liang, Songping
    Zhang, Gaihua
    Liu, Zhonghua
    Wang, Ying
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2024, 38 (01)
  • [49] DEVELOPMENT OF MECHANISM-BASED NOVEL DILI BIOMARKERS AND THERAPEUTIC INTERVENTIONS
    Antoine, Daniel J.
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S7 - S8
  • [50] Discovery of novel NLRP3 inhibitors enabled by a high-throughput screen
    Dorich, Stephane
    Auger, Anick
    Wang, Li
    Burch, Jason
    Pellerin, Charles
    Chan, Silas
    Raymond, Marianne
    Zhang, Lingling
    Chefson, Amandine
    Germain, Marie-Anne
    Jananji, Silvana
    Dumais, Valerie
    Gaudreault, Samuel
    Caron, Alexandre
    Dumas-Berube, Emilie
    Crackower, Michael. A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 122